Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 244Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Biophore India Pharmaceuticals Pvt Ltd

02 1ANDA Repository

03 1Amphastar Pharmaceuticals

04 1Annora Pharma

05 13Bayer AG

06 7Bracco

07 2Farmak JSC

08 8GE Healthcare Inc

09 5Mallinckrodt Pharmaceuticals

10 1Xian Libang Pharmaceutical Co.,Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Diatrizoate Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 76%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Diatrizoate Sodium; Diatrizoate Meglumine

Brand Name :

Dosage Form : Injection

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : DIATRIZOATE-60

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 52%;8%

Packaging :

Approval Date : 1983-06-17

Application Number : 88166

Regulatory Info : DISCN

Registration Country : USA

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 2022-06-27

Application Number : 214201

Regulatory Info : RX

Registration Country : USA

blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 2023-11-17

Application Number : 215049

Regulatory Info : RX

Registration Country : USA

blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : ANGIOVIST 370

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-09-23

Application Number : 87723

Regulatory Info : DISCN

Registration Country : USA

blank

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : ANGIOVIST 292

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 52%;8%

Packaging :

Approval Date : 1982-09-23

Application Number : 87724

Regulatory Info : DISCN

Registration Country : USA

blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : UROVIST SODIUM 300

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%

Packaging :

Approval Date : 1982-09-23

Application Number : 87725

Regulatory Info : DISCN

Registration Country : USA

blank

09

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : GASTROVIST

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-09-23

Application Number : 87728

Regulatory Info : DISCN

Registration Country : USA

blank

10

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOGRAFIN-76

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 10040

Regulatory Info : DISCN

Registration Country : USA

blank

11

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOGRAFIN-60

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 52%;8%

Packaging :

Approval Date : 1982-01-01

Application Number : 10040

Regulatory Info : DISCN

Registration Country : USA

blank

12

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOVIST II

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 28.5%;29.1%

Packaging :

Approval Date : 1982-01-01

Application Number : 10040

Regulatory Info : DISCN

Registration Country : USA

blank

13

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOVIST

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 34.3%;35%

Packaging :

Approval Date : 1982-01-01

Application Number : 10040

Regulatory Info : DISCN

Registration Country : USA

blank

14

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : GASTROGRAFIN

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 11245

Regulatory Info : RX

Registration Country : USA

blank

15

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOCAL-76

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1988-06-01

Application Number : 89347

Regulatory Info : DISCN

Registration Country : USA

blank

16

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Diatrizoate Sodium

Brand Name : Triombrast

Dosage Form : Solution for Injection

Dosage Strength : 60%

Packaging : 20ML

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Ukraine

blank

17

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Diatrizoate Sodium

Brand Name : Triombrast

Dosage Form : Solution for Injection

Dosage Strength : 76%

Packaging : 20ML

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Ukraine

blank

18

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank

19

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE SODIUM 20%

Dosage Form : SOLUTION;URETERAL

Dosage Strength : 20%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank

20

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank

21

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : HYPAQUE-M,90%

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 60%;30%

Packaging :

Approval Date : 1982-01-01

Application Number : 10220

Regulatory Info : DISCN

Registration Country : USA

blank

22

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : HYPAQUE-M,75%

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%;25%

Packaging :

Approval Date : 1982-01-01

Application Number : 10220

Regulatory Info : DISCN

Registration Country : USA

blank

23

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : FOR SOLUTION;ORAL, RECTAL

Dosage Strength : 100%

Packaging :

Approval Date : 1982-01-01

Application Number : 11386

Regulatory Info : DISCN

Registration Country : USA

blank

24

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 40%

Packaging :

Approval Date : 1982-01-01

Application Number : 11386

Regulatory Info : DISCN

Registration Country : USA

blank

25

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : HYPAQUE-76

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 86505

Regulatory Info : DISCN

Registration Country : USA

blank

26

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : MD-76R

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1989-09-29

Application Number : 19292

Regulatory Info : DISCN

Registration Country : USA

blank

27

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : MD-76

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 87073

Regulatory Info : DISCN

Registration Country : USA

blank

28

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : MD-60

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 52%;8%

Packaging :

Approval Date : 1982-01-01

Application Number : 87074

Regulatory Info : DISCN

Registration Country : USA

blank

29

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : MD-50

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%

Packaging :

Approval Date : 1982-01-01

Application Number : 87075

Regulatory Info : DISCN

Registration Country : USA

blank

30

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : MD-GASTROVIEW

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 87388

Regulatory Info : RX

Registration Country : USA

blank